CURIS, INC. Debt Securities, Available-for-sale
CURIS, INC. (CRIS) had Debt Securities, Available-for-sale of $18.36 million as of 2024-06-30, per its 10-Q filed 2024-08-01.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2025-03-31
- 2024-06-30: Debt Securities, Available-for-sale $18.36M.
- 2024-03-31: Debt Securities, Available-for-sale $10.76M.
- 2023-12-31: Debt Securities, Available-for-sale $29.65M.
- 2023-09-30: Debt Securities, Available-for-sale $44.03M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2024-06-30 | $18.36M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $10.76M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $29.65M 10-K · filed 2025-03-31 |
| 2023-09-30 | $44.03M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $43.66M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $40.06M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $65.97M 10-K · filed 2024-02-08 |
| 2022-09-30 | $68.84M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $73.19M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $102.19M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $99.83M 10-K · filed 2023-03-13 |
| 2021-09-30 | $96.81M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $85.66M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $57.32M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $53.45M 10-K · filed 2022-02-24 |
| 2020-06-30 | $1.00K 10-Q · filed 2020-08-04 |
| 2020-03-31 | $6.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $5.11M 10-K · filed 2021-03-16 |
| 2019-09-30 | $6.65M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $8.10M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $30.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $634.00K 10-K · filed 2020-03-19 |
| 2018-09-30 | $5.27M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $9.96M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $23.72M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $21.94M 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |